Merck & Co Inc reports results for the quarter ended December 31 - Earnings Summary

• Merck & Co Inc MRK.N reported quarterly adjusted earnings of $1.72​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of 3 cents. The mean expectation of sixteen analysts for the quarter was for earnings of $1.62 per share. Wall Street expected results to range from $1.59 to $1.68 per share.
• Revenue rose 6.8% to $15.62 billion from a year ago; analysts expected $15.49 billion.
• Merck & Co Inc's reported EPS for the quarter was $1.48​.
• The company reported quarterly net income of $3.74 billion.
• Merck & Co Inc shares had risen by 0.3% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 13.3% in the last three months.​
• In the last 30 days, eleven analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell."
• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Merck & Co Inc is $121.66

This summary was machine generated from LSEG data February 4 at 02:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)